Results 161 to 170 of about 29,868 (281)

ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus

open access: yes, 1997
To verify (1) how many patients with cutaneous lupus erythematosus (CLE) fulfill 4 or more American Rheumatism Association (ARA) and European Academy of Dermatology and Venereology (EADV) criteria for classification of systemic lupus erythematosus (SLE);
REBORA, ALFREDO, PARODI, AURORA
core  

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1137-1161, July 2026.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda   +31 more
wiley   +1 more source

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult [PDF]

open access: yesAdvances in Dermatology and Allergology, 2017
Mao, Qiu-Xia   +9 more
openaire   +2 more sources

Neonatal lupus erythematosus with persistent cutaneous telangiectases

open access: yes, 1998
Neonatal lupus erythematosus (NLE) is a rare disorder. It is characterized by cutaneous lesions and/or congenital heart block. Hematological abnormalities can be associated.
G. Tribbia, S.Menni
core  

Digital twins to accelerate target identification and drug development for immune‐mediated disorders

open access: yesFEBS Open Bio, Volume 16, Issue 6, Page 1048-1059, June 2026.
Digital twins integrate patient‐derived molecular and clinical data into personalised computational models that simulate disease mechanisms. They enable rapid identification and validation of therapeutic targets, prediction of drug responses, and prioritisation of candidate interventions.
Anna Niarakis, Philippe Moingeon
wiley   +1 more source

Role of Prednisone and 25‐Hydroxyvitamin D on Bone Mineral Density and Osteoporosis in Systemic Lupus Erythematosus

open access: yesArthritis Care &Research, Volume 78, Issue 6, Page 743-748, June 2026.
Objective We evaluated the role of 25‐hydroxyvitamin D (25[OH]D), prednisone, and other risk factors for bone mineral density (BMD) loss and osteoporosis in systemic lupus erythematosus (SLE). Methods We calculated the association between 25(OH)D levels and other potential risk factors and BMD measures (spine T scores) and osteoporosis (defined as a T ...
Nima Madanchi   +4 more
wiley   +1 more source

Nitrendipine-induced subacute cutaneous lupus erythematosus

open access: yes, 2003
A 66-year-old man presented with widespread annular and bullous subacute cutaneous lupus erythematosus (SCLE), developed after starting treatment for hypertension with the calcium channel blocker nitrendipine.
Caputo, Ruggero   +4 more
core  

Home - About - Disclaimer - Privacy